Sign Up
Stories
Genomic Tech's Investment Potential
Share
4DMT Presents Positive Interim Data
Agilent's GenetiSure Dx Certification
BeiGene to Present at J.P. Morgan Health...
BMY Expands Portfolio with RayzeBio Acqu...
Biotech Collaboration Deals Analysis
Biotech Collaboration Enhances Sector So...
Overview
API
Investors are increasingly drawn to health tech, bio tech, precision medicine, and diagnostics tech for their financial and healthcare potential. Genomic health and CRISPR technology are identified as promising fields, with the global genomics market expected to hit $83.1 billion by 2028.
Ask a question
How might the increasing investment in genomic technologies affect traditional healthcare practices?
In what ways could the growth of the genomics market influence the accessibility of personalized medicine globally?
What regulatory challenges could arise with the advancement of genomic health and CRISPR technology?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage